Results 81 to 90 of about 7,224 (167)

Tenofovir Alafenamide for HIV Preexposure Prophylaxis

Annals of Internal Medicine, 2020
Diana Brainard, Scott McCallister
openaire   +5 more sources

Tenofovir alafenamide fumarate use for HIV pre-exposure prophylaxis and weight gain. [PDF]

Sci Rep
Shi F, Xia H, Weissman S, Li X, Yang X.
europepmc   +1 more source

Tenofovir Alafenamide in the Treatment of Chronic Hepatitis B Virus Infection in the High-Replicative Low-Inflammatory Phase: A 48-Week Randomized Controlled Trial. [PDF]

J Med Virol
Luo Q, Xu R, Zhang Y, Xu W, Li X, Lai J, Li J, Zheng X, Deng H, Chen L, Zhu X, Xie C, Peng L.   +12 more
europepmc   +1 more source

Greater Reductions in Hepatitis B Core-Related Antigen Associated with Switching from Entecavir to Tenofovir Alafenamide Compared with Continued Entecavir Therapy: A Retrospective Observational Study. [PDF]

J Clin Med
Fukushima M, Miuma S, Nakao Y, Sasaki R, Haraguchi M, Miyaaki H.   +5 more
europepmc   +1 more source

Virological outcomes with Bictegravir/Emtricitabine/Tenofovir alafenamide (B/F/TAF) in people previously treated with darunavir-based antiretroviral therapy. [PDF]

HIV Med
Sheridan R, Osei-Kuffour Ekert Y, Campbell L, Zuckerman M, Hawkins S, Childs K, Post FA.   +6 more
europepmc   +1 more source

Tenofovir Alafenamide Fumarate Reduces Virological Replication in HBeAg-Negative Patients With Normal Alanine Aminotransferase: A 48-Week Randomised Controlled Trial. [PDF]

J Viral Hepat
Luo Q, Xu W, Zhang Y, Li X, Lai J, Li J, Zheng X, Deng H, Chen L, Zhu X, Xie C, Peng L.   +11 more
europepmc   +1 more source

HBV status modulates transaminase decrease after switching from tenofovir disoproxil fumarate to tenofovir alafenamide in people with HIV. [PDF]

J Antimicrob Chemother
Lapadula G, Soria A, Antolini L, Rugova A, Colella E, Sabbatini F, Squillace N, Mezzadri L, Limonta S, Cappelletti A, Ranzani A, Bonfanti P.   +11 more
europepmc   +1 more source

Evaluating the Efficacy of Crushed Bictegravir/Emtricitabine/Tenofovir Alafenamide Administered via Tube. [PDF]

Open Forum Infect Dis
Mercure J, Bey K, Gillett E, Pearson JC, McCluskey SM, Rock AE.   +5 more
europepmc   +1 more source

Impact of Tenofovir Alafenamide Sub-Dermal Implant Insertion Site Scarring on Acceptability and HIV Prevention Preferences: A Prospective Cohort Study in Durban, South Africa. [PDF]

J Int AIDS Soc
Gengiah TN, Lewis L, Harkoo I, Myeni N, Mansoor LE, Karim SSA, Karim QA.   +6 more
europepmc   +1 more source

Resistance Analyses of Lenacapavir, Emtricitabine/Tenofovir Alafenamide and Emtricitabine/Tenofovir Disoproxil Fumarate in the PURPOSE 1 and 2 Studies. [PDF]

J Infect Dis
Cox S, Andreatta K, Hendricks MR, Li J, Kintu A, Brown LB, Carter CC, Callebaut C.   +7 more
europepmc   +1 more source